Pharmaceutical

Biotech execs say IRA is causing unintended effects for cancer drug development

IRA regulations have changed how pharma is approaching innovation in cancer drug discovery and development.

Feb 28, 2024 - 18:00
Biotech execs say IRA is causing unintended effects for cancer drug development
IRA regulations have changed how pharma is approaching innovation in cancer drug discovery and development.
Read the original article

Tags:

Previous Article

Biotechs heed political headwinds for drug pricing negotiations and partnerships

Next Article

Beyond approval: Patients pursue alternate paths to get rare disease treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Half of top 20 biopharma company market cap impacted amid the IRA in Q3 2023

Half of top 20 biopharma company market cap impacted am...

Oct 31, 2023

STAT+: $100 billion estimate for Ozempic-style weight loss drugs gets wary eye from analysts

STAT+: $100 billion estimate for Ozempic-style weight l...

Dec 5, 2023

Market cap rebound by top 20 biopharmaceutical companies in Q2 2023

Market cap rebound by top 20 biopharmaceutical companie...

Sep 15, 2023